Piccadily Agro Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:57 pm

Quick Insight

Piccadily Agro Industries Ltd, a player in the sugar industry, currently trades at ₹632 with a market capitalization of ₹6,008 Cr. The stock's high P/E ratio of 58.7 indicates a premium investors are willing to pay for future growth potential. With a robust ROE of 20.1% and ROCE of 22.7%, the company demonstrates efficient capital utilization. However, a relatively high debt level of ₹308 Cr against reserves of ₹586 Cr raises concerns about leverage. The concentrated ownership with promoters holding 70.97% highlights alignment but also potential governance risks. Overall, investors should closely monitor the company's debt position and governance practices to make informed investment decisions.

Competitors of Piccadily Agro Industries Ltd

All Competitor Stocks of Piccadily Agro Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:28 am

Below is a detailed analysis of the quarterly data for Piccadily Agro Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 255.00 Cr.. The value appears strong and on an upward trend. It has increased from 182.00 Cr. (Dec 2024) to 255.00 Cr., marking an increase of 73.00 Cr..
• For Expenses, as of Mar 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 135.00 Cr. (Dec 2024) to 190.00 Cr., marking an increase of 55.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 48.00 Cr. (Dec 2024) to 66.00 Cr., marking an increase of 18.00 Cr..
• For OPM %, as of Mar 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 26.00%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Dec 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 9.00 Cr..
• For Depreciation, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 18.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Dec 2024) to 26.00%, marking a decrease of 6.00%.
• For Net Profit, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Dec 2024) to 40.00 Cr., marking an increase of 15.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.23. The value appears strong and on an upward trend. It has increased from 2.63 (Dec 2024) to 4.23, marking an increase of 1.60.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:09 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:32 pm

Below is a detailed analysis of the balance sheet data for Piccadily Agro Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 94.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 94.00 Cr..
• For Reserves, as of Mar 2025, the value is 586.00 Cr.. The value appears strong and on an upward trend. It has increased from 245.00 Cr. (Mar 2024) to 586.00 Cr., marking an increase of 341.00 Cr..
• For Borrowings, as of Mar 2025, the value is 308.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 172.00 Cr. (Mar 2024) to 308.00 Cr., marking an increase of 136.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 156.00 Cr.. The value appears to be improving (decreasing). It has decreased from 228.00 Cr. (Mar 2024) to 156.00 Cr., marking a decrease of 72.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,144.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 739.00 Cr. (Mar 2024) to 1,144.00 Cr., marking an increase of 405.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 282.00 Cr.. The value appears strong and on an upward trend. It has increased from 218.00 Cr. (Mar 2024) to 282.00 Cr., marking an increase of 64.00 Cr..
• For CWIP, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 159.00 Cr..
• For Investments, as of Mar 2025, the value is 60.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2024) to 60.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 601.00 Cr.. The value appears strong and on an upward trend. It has increased from 419.00 Cr. (Mar 2024) to 601.00 Cr., marking an increase of 182.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,144.00 Cr.. The value appears strong and on an upward trend. It has increased from 739.00 Cr. (Mar 2024) to 1,144.00 Cr., marking an increase of 405.00 Cr..

Notably, the Reserves (586.00 Cr.) exceed the Borrowings (308.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Piccadily Agro Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.85. This value is within the healthy range. It has decreased from 11.63 (Mar 24) to 10.85, marking a decrease of 0.78.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.84. This value is within the healthy range. It has decreased from 11.63 (Mar 24) to 10.84, marking a decrease of 0.79.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.95. This value is within the healthy range. It has decreased from 13.63 (Mar 24) to 12.95, marking a decrease of 0.68.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.09. It has increased from 36.01 (Mar 24) to 72.09, marking an increase of 36.08.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.09. It has increased from 36.01 (Mar 24) to 72.09, marking an increase of 36.08.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 86.72. It has increased from 82.62 (Mar 24) to 86.72, marking an increase of 4.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 20.09. This value is within the healthy range. It has increased from 16.00 (Mar 24) to 20.09, marking an increase of 4.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.02. This value is within the healthy range. It has increased from 14.07 (Mar 24) to 18.02, marking an increase of 3.95.
• For PBT / Share (Rs.), as of Mar 25, the value is 15.07. This value is within the healthy range. It has decreased from 15.52 (Mar 24) to 15.07, marking a decrease of 0.45.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.89. This value is within the healthy range. It has decreased from 11.70 (Mar 24) to 10.89, marking a decrease of 0.81.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.85. This value is within the healthy range. It has decreased from 11.63 (Mar 24) to 10.85, marking a decrease of 0.78.
• For PBDIT Margin (%), as of Mar 25, the value is 23.16. This value is within the healthy range. It has increased from 19.36 (Mar 24) to 23.16, marking an increase of 3.80.
• For PBIT Margin (%), as of Mar 25, the value is 20.78. This value exceeds the healthy maximum of 20. It has increased from 17.02 (Mar 24) to 20.78, marking an increase of 3.76.
• For PBT Margin (%), as of Mar 25, the value is 17.38. This value is within the healthy range. It has decreased from 18.77 (Mar 24) to 17.38, marking a decrease of 1.39.
• For Net Profit Margin (%), as of Mar 25, the value is 12.55. This value exceeds the healthy maximum of 10. It has decreased from 14.16 (Mar 24) to 12.55, marking a decrease of 1.61.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.50. This value is within the healthy range. It has decreased from 14.08 (Mar 24) to 12.50, marking a decrease of 1.58.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has decreased from 32.31 (Mar 24) to 15.04, marking a decrease of 17.27.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.09. This value is within the healthy range. It has decreased from 30.61 (Mar 24) to 20.09, marking a decrease of 10.52.
• For Return On Assets (%), as of Mar 25, the value is 8.94. This value is within the healthy range. It has decreased from 14.85 (Mar 24) to 8.94, marking a decrease of 5.91.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.20, marking an increase of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.45. This value is within the healthy range. It has decreased from 0.50 (Mar 24) to 0.45, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.86. It has decreased from 1.17 (Mar 24) to 0.86, marking a decrease of 0.31.
• For Current Ratio (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.85, marking an increase of 0.54.
• For Quick Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.83, marking an increase of 0.17.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.67. This value is below the healthy minimum of 4. It has decreased from 1.88 (Mar 24) to 1.67, marking a decrease of 0.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.71 (Mar 24) to 0.00, marking a decrease of 1.71.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.47 (Mar 24) to 0.00, marking a decrease of 1.47.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.29 (Mar 24) to 0.00, marking a decrease of 98.29.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.53 (Mar 24) to 0.00, marking a decrease of 98.53.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has decreased from 9.60 (Mar 24) to 6.81, marking a decrease of 2.79.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.69. This value is within the healthy range. It has decreased from 6.15 (Mar 24) to 4.69, marking a decrease of 1.46.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,589.36. It has increased from 3,001.84 (Mar 24) to 5,589.36, marking an increase of 2,587.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.83. This value exceeds the healthy maximum of 3. It has increased from 3.85 (Mar 24) to 6.83, marking an increase of 2.98.
• For EV / EBITDA (X), as of Mar 25, the value is 29.49. This value exceeds the healthy maximum of 15. It has increased from 19.89 (Mar 24) to 29.49, marking an increase of 9.60.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.51. This value exceeds the healthy maximum of 3. It has increased from 3.65 (Mar 24) to 6.51, marking an increase of 2.86.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 98.28 (Mar 24) to 0.00, marking a decrease of 98.28.
• For Price / BV (X), as of Mar 25, the value is 7.84. This value exceeds the healthy maximum of 3. It has decreased from 8.39 (Mar 24) to 7.84, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.51. This value exceeds the healthy maximum of 3. It has increased from 3.65 (Mar 24) to 6.51, marking an increase of 2.86.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness